Hans Hofstraat is Vice President and Innovation Program Manager at Philips Chief Technology Office (CTO), as well as member of the CTO Management Team. As Innovation Program Manager, Hans works with teams within Philips Research, and with colleagues within the CTO and in Business and Markets across the globe, on innovations in clinical domains such as Oncology, Neurology, and towards universal and equitable Access to Care, combining clinical insights with the opportunities offered by digital healthcare. Nationally, he is on the Dutch Sounding Board for Horizon 2020, contributing to work on Health, Demographic Change and Well-being, a member of the Steering Committee and co-initiator of the big data initiative of the Top Sector Life Sciences & Health and a member of the Management Team of the Institute for Diagnostic and Interventional Imaging (IDII) in which Philips participates together with the University Medical Center Utrecht, Utrecht University and Eindhoven University of Technology. He is on steering committees of several public-private partnerships, e.g. with the Karolinska Hospital in Stockholm, the Leiden University Medical Center in the Netherlands, the Dana Farber Cancer Institute in Boston, and Tohoku University and Hospital in Japan.

Hans joined Philips Research from Akzo Nobel Central Research in 1998. He was originally trained as a chemist, earning the Unilever Prize for his BSc (cum laude), and completing his physical chemistry PhD thesis on low-temperature high-resolution luminescence spectroscopy at the Free University Amsterdam, for which he was awarded the Royal Dutch Shell prize. He completed a post-doc at the Eidgenössische Technische Hochschule in Zürich, Switzerland.

Dr Hofstraat has authored about 200 publications with an h-index of 42 (Google Scholar), and also holds 10 granted US patents, with more than 80 patent applications in various countries, covering 25 patent families across a range of fields.